Triveni Bio
Nicholas Scarchilli is an experienced professional currently serving as Entrepreneur in Residence at Atlas Venture and Chief Operating Officer at Triveni Bio. Prior to their current roles, Nicholas held various executive positions at companies such as Amagma Therapeutics, Biogen, and Huron, where Nicholas focused on business development, operations, and corporate strategy in the life sciences industry. Nicholas holds a Master of Business Administration from The Tuck School of Business at Dartmouth and a BBA in Corporate Finance from the University of Massachusetts Amherst.
This person is not in any teams
Triveni Bio
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establishes proof-of-concept at the earliest stages of drug development. Through a strong understanding of genetics and mechanistic biology, our pipeline is powered for indication expansion where we know we can have the most impact. To learn more, visit www.triveni.bio.